These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9204185

  • 1. Growth hormone- and growth-hormone-releasing hormone-producing tumors.
    Shimon I, Melmed S.
    Cancer Treat Res; 1997; 89():1-24. PubMed ID: 9204185
    [No Abstract] [Full Text] [Related]

  • 2. Intrasellar pituitary gangliocyto-adenoma presenting with acromegaly: case report.
    Puchner MJ, Herrmann HD.
    Neurosurgery; 1998 May; 42(5):1197-9. PubMed ID: 9588573
    [No Abstract] [Full Text] [Related]

  • 3. Medical progress: Acromegaly.
    Melmed S.
    N Engl J Med; 2006 Dec 14; 355(24):2558-73. PubMed ID: 17167139
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Combined neuronal and endocrine tumors of the sellar region].
    Saeger W, Lüdecke DK, Losa M.
    Pathologe; 1997 Nov 14; 18(6):419-24. PubMed ID: 9451729
    [Abstract] [Full Text] [Related]

  • 6. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R.
    J Clin Endocrinol Metab; 2006 Jan 14; 91(1):85-92. PubMed ID: 16263832
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Growth hormone-releasing hormone (GHRH)].
    Katakami H.
    Nihon Rinsho; 2005 Aug 14; 63 Suppl 8():166-71. PubMed ID: 16149479
    [No Abstract] [Full Text] [Related]

  • 12. Acromegaly: a fascinating pituitary disorder. Introduction.
    Vance ML.
    Neurosurg Focus; 2010 Oct 14; 29(4):Introduction. PubMed ID: 20887135
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endocrine applications of the somatostatin analogue octreotide (Sandostatin).
    Ezzat S, Melmed S.
    Metabolism; 1992 Sep 14; 41(9 Suppl 2):34-8. PubMed ID: 1518431
    [No Abstract] [Full Text] [Related]

  • 15. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L, Starke RM, Jane JA, Oldfield EH.
    J Neurosurg; 2015 Apr 14; 122(4):798-802. PubMed ID: 25423276
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z, Sakurai K, Osaki Y, Fukazawa H, Yamada S, Inoshita N, Murakami O, Ohba K, Takahashi K.
    Endocr J; 2011 Apr 14; 58(12):1029-36. PubMed ID: 21908929
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Consensus on the change of criteria for cure of acromegaly during the last decade].
    Kovács GL, Dénes J, Hubina E, Kovács L, Czirják S, Góth M.
    Orv Hetil; 2011 May 01; 152(18):703-8. PubMed ID: 21498158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.